Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $456.22 | 28 | 61.6% |
| Education | $283.95 | 5 | 38.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $118.20 | 2 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $99.99 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $97.12 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.10 | 5 | $0 (2024) |
| Ardelyx, Inc. | $75.71 | 4 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $55.10 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $43.81 | 3 | $0 (2019) |
| Baxter Healthcare | $26.71 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $25.54 | 2 | $0 (2018) |
| Vifor Pharma, Inc. | $22.65 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.90 | 10 | Ardelyx, Inc. ($57.23) |
| 2023 | $18.48 | 1 | Ardelyx, Inc. ($18.48) |
| 2021 | $146.39 | 3 | Mallinckrodt Hospital Products Inc. ($99.99) |
| 2019 | $217.78 | 6 | Mallinckrodt Enterprises LLC ($99.99) |
| 2018 | $75.34 | 6 | AstraZeneca Pharmaceuticals LP ($25.54) |
| 2017 | $102.28 | 7 | Otsuka America Pharmaceutical, Inc. ($24.83) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Hyperkalemia | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: NEPHROLOGY | ||||||
| 05/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 01/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/09/2021 | Baxter Healthcare | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Renal | ||||||
| 12/03/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DIABETES | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 04/09/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Hyperparathyroidism | ||||||
| 11/28/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Oncology | ||||||
| 10/09/2018 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Nephrology | ||||||
| 10/03/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/06/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEPHROLOGY | ||||||
| 02/22/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,077 | 2,022 | $480,910 | $215,643 |
| 2022 | 16 | 1,176 | 2,180 | $533,228 | $248,351 |
| 2021 | 20 | 1,118 | 1,918 | $418,478 | $199,249 |
| 2020 | 21 | 1,309 | 2,379 | $501,155 | $220,038 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 177 | $88,050 | $48,618 | 55.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 298 | 746 | $119,360 | $45,703 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 409 | $80,021 | $37,016 | 46.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 34 | 109 | $45,712 | $24,885 | 54.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 13 | 76 | $34,039 | $17,251 | 50.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 72 | $28,008 | $9,546 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 94 | $27,448 | $9,357 | 34.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 96 | 97 | $20,370 | $8,475 | 41.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 66 | 130 | $13,650 | $5,049 | 37.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 46 | $8,602 | $4,280 | 49.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $8,970 | $3,409 | 38.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 23 | $4,600 | $1,285 | 27.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $2,080 | $768.65 | 37.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 45 | 236 | $111,030 | $66,627 | 60.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 275 | 735 | $117,600 | $40,236 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 307 | 413 | $80,948 | $39,228 | 48.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 44 | 113 | $43,390 | $26,241 | 60.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 16 | 100 | $45,000 | $23,115 | 51.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 66 | 70 | $27,230 | $10,780 | 39.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 88 | 94 | $27,448 | $9,861 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $18,060 | $7,256 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 78 | $14,586 | $6,168 | 42.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 63 | 63 | $13,230 | $5,165 | 39.0% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 42 | 74 | $9,990 | $3,986 | 39.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 24 | 25 | $3,800 | $2,120 | 55.8% |
About Dr. Shalanki Baiswar, MD
Dr. Shalanki Baiswar, MD is a Hospitalist healthcare provider based in Chambersburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1740431220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shalanki Baiswar, MD has received a total of $740.17 in payments from pharmaceutical and medical device companies, with $179.90 received in 2024. These payments were reported across 33 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($456.22).
As a Medicare-enrolled provider, Baiswar has provided services to 4,680 Medicare beneficiaries, totaling 8,499 services with total Medicare billing of $883,281. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine, Nephrology
- Location Chambersburg, PA
- Active Since 10/02/2008
- Last Updated 01/15/2026
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1740431220
Products in Payments
- ACTHAR (Biological) $218.19
- SAMSCA (Drug) $97.12
- IBSRELA (Drug) $75.71
- JARDIANCE (Drug) $72.94
- XARELTO (Drug) $43.81
- Rayaldee (Drug) $36.54
- Renal - CRRT (Device) $26.71
- Veltassa (Drug) $22.65
- Velphoro (Drug) $21.44
- LUPKYNIS (Drug) $19.69
- INJECTAFER (Drug) $19.48
- RAYALDEE (Drug) $18.56
- Auryxia (Drug) $15.08
- IMFINZI (Drug) $14.29
- PRADAXA (Drug) $12.16
- Baxdela (Drug) $11.47
- BRILINTA (Drug) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Chambersburg
Muhammad Janjua, M.d, M.D
Hospitalist — Payments: $2,941
Dr. Umer Khan
Hospitalist — Payments: $1,652
Abdul Cheema, M.d, M.D
Hospitalist — Payments: $572.22
Geraldine Policard, Md, MD
Hospitalist — Payments: $244.52
Ryan Decort, Do, DO
Hospitalist — Payments: $233.20
Hersh Shah, Md, MD
Hospitalist — Payments: $142.98